EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 4.0

Erratum

Liver Cancer · 27.05.2026 · 1-1

DOI: 10.1159/000552217 ↗

Kurz gefasst

Korrektur in der Zeitschrift Liver Cancer, online erschienen am 27.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

In the article “Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis” [Liver Cancer. 2025; https://doi.org/10.1159/000549955] by Chan et al., the copyright license has been changed to a CC-BY 4.0 license. The original online article has been updated to reflect this.

Zitieren

APA

(2026). Erratum. Liver Cancer, 1-1. https://doi.org/10.1159/000552217

Vancouver

Erratum. Liver Cancer. 2026:1-1. doi:10.1159/000552217

BibTeX
@article{euvimed2026,
  title = {Erratum},
  journal = {Liver Cancer},
  year = {2026},
  pages = {1--1},
  doi = {10.1159/000552217}
}
Kostenlos starten →